Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients
Analytical and Bioanalytical Chemistry · 2026-11 · 418 (22) · 7339-7352
DOI: 10.1007/s00216-026-06728-3 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 18.08.2026. Verfasst von Ya-Chu Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Science and Technology Council, Taiwan.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Tamoxifen requires biotransformation into metabolites to exert antiestrogenic activity, and variability in metabolite exposure contributes to interindividual differences in clinical outcomes. Volumetric absorptive microsampling (VAMS) provides a convenient and minimally invasive alternative for therapeutic drug monitoring (TDM). However, analytical methods enabling comprehensive quantification of tamoxifen and its metabolites in VAMS remain limited, and translation of VAMS-derived concentrations into plasma-equivalent values has not been well established. In this study, an LC-MS/MS method was developed and fully validated for simultaneous quantification of tamoxifen and six metabolites in VAMS samples. Water prerinsing prior to methanol extraction improved analyte recoveries to 89.2-111.2%. Stability evaluation of VAMS samples revealed poor room-temperature stability for most analytes, whereas all analytes remained stable for at least 100 days at -80 °C. Experimentally derived plasma-to-blood concentration ratios (Cp/Cb, 1.41-1.83) were further applied to estimate plasma-equivalent concentrations from VAMS samples. Clinical applicability was evaluated using paired VAMS and plasma samples collected from ten tamoxifen-treated breast cancer patients. Strong correlations between VAMS-derived and measured plasma concentrations were observed (R2 = 0.77-0.98). Bland-Altman analysis further demonstrated good agreement, with more than 90% of values falling within the ±1.96 SD limits. These results demonstrate that the proposed workflow provides a reliable approach for comprehensive tamoxifen metabolite quantification in VAMS samples and supports plasma-equivalent concentration estimation for comparison with existing plasma-based therapeutic data. The proposed strategy may facilitate the clinical implementation of VAMS-based TDM for personalized tamoxifen therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan.
- Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
- School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan. ljshen@ntu.edu.tw.
- Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. ljshen@ntu.edu.tw.
- Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan. ljshen@ntu.edu.tw.
- School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan. kuoch@ntu.edu.tw.
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Kuo, Y. C., Huang, H. Y., Ho, H. H., Shen, L. J., & Kuo, C. H. (2026). Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients. Analytical and Bioanalytical Chemistry, 418(22), 7339-7352. https://doi.org/10.1007/s00216-026-06728-3
Vancouver
Kuo YC, Huang HY, Ho HH, Shen LJ, Kuo CH. Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients. Analytical and Bioanalytical Chemistry. 2026;418(22):7339-7352. doi:10.1007/s00216-026-06728-3
BibTeX
@article{Kuo2026,
author = {Kuo, Ya-Chu and Huang, Hsuan-Yu and Ho, Hsuan-Hui and Shen, Li-Jiuan and Kuo, Ching-Hua},
title = {Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients},
journal = {Analytical and Bioanalytical Chemistry},
year = {2026},
volume = {418},
number = {22},
pages = {7339--7352},
doi = {10.1007/s00216-026-06728-3}
}
EUVIMED